
0:00
15:30
Bempedoic Acid aka Nexletol has a new trial in NEJM that shows MACE reduction in very high risk patients (mostly secondary but some primary prevention). NNT? NNH? Other trials on Bempedoic acid? Tune in and find out.
Flere episoder fra "Primary Care Pod"
Gå ikke glip af nogen episoder af “Primary Care Pod” - abonnér på podcasten med gratisapp GetPodcast.